Religious/Spiritual Struggle in Young Adult Hematopoietic Cell Transplant Survivors

Journal of Adolescent and Young Adult Oncology
Stephen D W KingRebecca H Johnson

Abstract

This study describes the prevalence of religious and/or spiritual (R/S) struggle in long-term young adult (YA) survivors following hematopoietic cell transplantation (HCT) as well as existential concerns (EC), social support, and demographic, medical, and emotional correlates of R/S struggle. Data were collected as part of an annual survey of survivors of HCT aged 18-39 years at survey completion; age at HCT was 1-39 years. Study measures included measures of R/S struggle (defined as any non-zero response on the negative religious coping subscale from Brief RCOPE), quality of life (QOL), and depression. Factors associated with R/S struggle were identified using multivariable logistic regression models. Fifty-two of the 172 respondents (30%), who ranged from less than a year to 33 years after HCT, had some R/S struggle. In bivariate analysis, depression was associated with R/S struggle. In a multivariable logistic regression model, individuals with greater EC were nearly five times more likely to report R/S struggle. R/S struggle was not associated with age at transplant, time since transplant, gender, race, R/S self-identification, or medical variables. R/S struggle is common among YA HCT survivors, even many years after HCT. T...Continue Reading

References

Apr 25, 2000·Journal of Clinical Psychology·K I PargamentL M Perez
Sep 25, 2004·International Journal of Psychiatry in Medicine·George FitchettJudy A Davis
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N BoscagliaM A Quinn
Jun 7, 2006·Journal of Palliative Medicine·Nalini TarakeshwarHolly G Prigerson
Oct 16, 2008·Journal of Behavioral Medicine·Allen C ShermanElias J Anaissie
May 6, 2009·Journal of Pediatric Hematology/oncology·Sian CottonJoel Tsevat
Apr 10, 2010·American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses·Susan J PresslerRebecca Sloan
Aug 25, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M ThomasAndrea Ferrari
Jan 12, 2011·Journal of Personality and Social Psychology·Julie J ExlineMichael P Carey
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brad Zebrack, Sinéad Isaacson
Feb 15, 2013·Journal of Palliative Medicine·Julie J ExlineKaren S Peereboom
May 2, 2013·Journal of Health Psychology·George FitchettKenneth I Pargament
May 24, 2013·Current Oncology Reports·Claudia L Epelman
Apr 29, 2014·Journal of Pain and Symptom Management·Karin OechsleAnja Mehnert
Apr 29, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Judith R RagsdaleStella Davies
Nov 17, 2015·Psycho-oncology·Stephen Duane KingElizabeth Trice Loggers
Jun 30, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Bibi Hølge-HazeltonCecilie Dyg Sperling
Oct 8, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Stephen D W KingElizabeth Trice Loggers

❮ Previous
Next ❯

Citations

May 11, 2018·Current Opinion in Oncology·Carla I RipamontiGuido Miccinesi
Nov 5, 2020·Journal of Adolescent and Young Adult Oncology·Stephen D W KingRebecca H Johnson
Dec 7, 2021·Journal of Palliative Medicine·Allison KestenbaumArif H Kamal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Stephen D W KingElizabeth Trice Loggers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Karen L SyrjalaPaul J Martin
© 2022 Meta ULC. All rights reserved